Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| piCRAC-1 | C17H10F6N4 | 2418049-54-2 | Details |
| (1R,2R)-ML-SI3 | C23H31N3O3S | 2418594-00-8 | Details |
| ERAP2-IN-1 | C20H21F3N2O5S | 2420551-38-6 | Details |
| Cilgavimab | 2420563-99-9 | Details |
| Tixagevimab | 2420564-02-7 | Details |
| Sotrovimab | 2423014-07-5 | Details |
| Bamlanivimab | 2423943-37-5 | Details |
| Etesevimab | 2423948-94-9 | Details |
| S1R agonist 1 hydrochloride | C20H25NO.ClH | 242487-82-7 | Details |
| DSM502 | C16H16F3N3O | 2426616-55-7 | Details |
| TP0586532 | C26H28N4O4 | 2427584-96-9 | Details |
| MSU-42011 | C24H34N2O2 | 2456434-36-7 | Details |
| TP0427736 hydrochloride | C14H11ClN4S2 | 2459963-17-6 | Details |
| Mupadolimab | 2451856-97-4 | Details |
| FC9402 | C19H16N4O | 2452401-65-7 | Details |
| UB 165 fumarate | C13H15ClN2.C4H4O4 | 2454492-43-2 | Details |
| SCH79797 | C23H25N5 | 245520-69-8 | Details |
| EP4-IN-1 | C27H24N2O4 | 2455480-28-9 | Details |
| Glyoxalase I inhibitor 6 | C18H15N3O5S | 2455508-19-5 | Details |
| X77 | C27H33N5O2 | 2455518-33-7 | Details |
| Dihydrocubebin | C20H22O6 | 24563-03-9 | Details |
| SD-36 | C59H62F2N9O12P | 2429877-44-9 | Details |
| Befiradol hydrochloride | C20H23Cl2F2N3O | 2436760-81-3 | Details |
| ALV1 | C25H23ClN4O5 | 2438124-79-7 | Details |
| Tandutinib hydrochloride | C31H42N6O4.ClH | 2438900-70-8 | Details |
| MAT2A-IN-9 | C14H8ClF3N4O | 2439277-80-0 | Details |
| Gavilimomab | 244096-20-6 | Details |
| ND-011992 | C21H14F3N3O | 2446880-46-0 | Details |
| PROTAC PD-1/PD-L1 degrader-1 | C59H58ClN7O11 | 2447066-37-5 | Details |
| JMV 2959 hydrochloride (925238-89-7 free base) | C30H32N6O2.ClH | 2448414-54-6 | Details |
| BAY-888 | C28H26FN5O2 | 2468783-75-5 | Details |
| HOIPIN-1 | C17H14O4.Na | 2470242-33-0 | Details |
| USP8-IN-2 | C19H20ClF3N4OS | 2477651-11-7 | Details |
| SIRT1-IN-2 | C13H15ClN2O | 2470969-89-0 | Details |
| ALK-IN-26 | C24H23NO3S | 2447607-85-2 | Details |
| PARP1-IN-11 | C16H12N2O4 | 2482484-87-5 | Details |
| APOL1-IN-1 | C21H20FN3O3 | 2446817-72-5 | Details |
| VitaminA-d6 | C20H30O | 2483831-77-0 | Details |
| BB-Cl-Amidine hydrochloride | C26H27Cl2N5O | 2436747-41-8 | Details |
| Clesrovimab | 2429913-18-6 | Details |
| JAK2/STAT3-IN-1 | C34H35BrF3N5O2 | 2485758-50-5 | Details |
| GLUT4-IN-2 | C17H11N3O4S2 | 2454113-83-6 | Details |
| Burfiralimab | 2460809-80-5 | Details |
| IL-2-IN-1 | C17H12F6N4O2 | 245747-10-8 | Details |
| GLP-1R agonist 3 | C31H28FN5O4 | 2428640-18-8 | Details |
| Anticancer agent 46 | C15H14ClN3OS | 2426686-17-9 | Details |
| JB062 | C19H17NO4 | 2417988-00-0 | Details |
| VT107 | C25H20F3N3O | 2417718-63-7 | Details |
| VT-105 | C24H18F3N3O | 2417718-38-6 | Details |
| AMPK-IN-3 | C25H33N5O3 | 2417674-27-0 | Details |
| (4-NH2)-Exatecan | C23H21N3O4 | 2495742-21-5 | Details |
| YX-2-107 | C45H51N11O9 | 2417408-46-7 | Details |
| Sevasemten | C16H11F4N5O2 | 2417395-15-2 | Details |
| mPEG-DSPE sodium | C45H88NO11P | 247925-28-6 | Details |
| USP8-IN-3 | C18H18F3N5O2S | 2477651-10-6 | Details |
| (Rac)-5-Hydroxymethyl Tolterodine hydrochloride | C22H32ClNO2 | 250214-40-5 | Details |
| AXC-715 trihydrochloride | C18H26ClN5 | 2479276-17-8 | Details |
| BPR1R024 | C24H21F3N6O2 | 2503015-75-4 | Details |
| Dazolicin HCl | C17H24ClN3S.ClH | 24484-40-0 | Details |
| BMS-986365 | C41H45F3N8O5S | 2446928-30-7 | Details |
| (24Rac)-Campesterol-d7 | C28H48O | 2483832-11-5 | Details |
| MAT2A inhibitor 3 | C16H14ClN3O | 2439271-82-4 | Details |
| Glyoxalase I inhibitor 5 | C16H14N4O3S | 2455508-17-3 | Details |
| Mavacamten-d6 | C15H13D6N3O2 | 2453251-18-6 | Details |
| mTOR inhibitor-8 | C24H19ClN4OS | 2489196-70-3 | Details |
| CHET3 | C21H21N5O3S | 2489231-47-0 | Details |
| Torachrysone tetraglucoside | C38H54O24 | 245724-10-1 | Details |
| Torachrysone gentiobioside | C26H34O14 | 245724-09-8 | Details |
| Nor-rubrofusarin gentiobioside | C26H30O15 | 245724-08-7 | Details |
| M4K2234 | C27H31FN4O2 | 2421141-51-5 | Details |
| PD-1/PD-L1-IN-14 | C24H24N4O2 | 2499965-12-5 | Details |
| Lemalesomab | 250242-54-7 | Details |
| SRT 1720 dihydrochloride | C25H24ClN7OS | 2468639-77-0 | Details |
| Simufilam hydrochloride | C15H22ClN3O | 2480226-07-9 | Details |
| JAK-IN-21 | C19H16N8O | 2445499-20-5 | Details |
| MSC-4381 | C26H20ClN3O6S | 2445185-57-7 | Details |
| Macropa-NH2 hydrochloride | C26H38ClN5O8 | 2443966-86-5 | Details |
| PCAF-IN-1 | C15H11ClN6 | 2439194-86-0 | Details |
| CBP/p300 ligand 2 | C27H34F2N8O | 2484741-78-6 | Details |
| FHT-1204 | C24H23N5O5S2 | 2468048-24-8 | Details |
| BTB09089 | C14H12Cl2N4OS2 | 245728-44-3 | Details |
| TDO-IN-1 | C16H13F3N4O2 | 2490672-92-7 | Details |
| AMPK activator 4 | C24H21ClN2O3 | 2493239-46-4 | Details |
| MPO-IN-1 | C24H21ClN4 | 2471981-21-0 | Details |
| MRGPRX4 modulator-2 | C15H9ClF4O3 | 2492595-24-9 | Details |
| ULK1-IN-2 | C19H16BrFN4O6 | 2497409-01-3 | Details |
| 2-Thiopheneacetamide, α-[(2-bromoacetyl)(3-chloro-4-methoxyphenyl)amino]-N-(2-phenylethyl)- | C23H22BrClN2O3S | 2417552-84-0 | Details |
| Anticancer agent 43 | C14H9FN2O3S2 | 2470015-35-9 | Details |
| hCAIX-IN-5 | C18H12FNO3 | 2451479-57-3 | Details |
| 4,4'-Sulfonyldiphenol-d8 | C12H10O4S | 2483831-28-1 | Details |
| Regdanvimab | 2444308-95-4 | Details |
| Pom-8PEG | C29H43N3O12 | 2488761-03-9 | Details |
| RMC-0331 | C22H25ClF3N5O3 | 2488788-52-7 | Details |
| hPL-IN-2 | C19H11Cl4NO3 | 24900-61-6 | Details |
| Pomalidomide-amino-PEG5-NH2 hydrochloride | C25H35ClN4O10 | 2421217-05-0 | Details |
| Thalidomide-O-C5-NH2 hydrochloride | C18H22ClN3O5 | 2419145-66-5 | Details |
| Lartesertib | C23H21FN6O3 | 2495096-26-7 | Details |
| STM3006 | C25H27BrN8 | 2499664-52-5 | Details |
| MTK458 | C17H15F3N4 | 2499962-58-0 | Details |
| Product Total： Product Page： | ||||
| 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||